Memorial Sloan Kettering Cancer Center

Multidisciplinary Tumor Board on Uterine Sarcoma: MSK and Fortis

Gynecological cancers are the leading causes of cancer morbidity and mortality for women in India. To spread knowledge, further research, and improve patient outcomes, Memorial Sloan Kettering Cancer Center (MSK) in New York is excited to present an educational series between MSK and the leading institutions of India. For this event, we are honored to partner with Fortis Healthcare in Gurugram, India. We will be discussing the following cases and lectures on endometrial stromal sarcoma (ESS) and uterine leiyomyosarcoma (LMS):

Case 1: ESS: Low Grade or High Grade? A Difficult Case
(Presented by: Fortis Senior Resident of Medical Oncology Dr. Pavitra Vijayraghavan)

Presentation 1 Pathological Dilemma of ESS
(Presented by: Fortis Pathologist Dr. Sunita Ahlawat)

Case 2: Uterine LMS: Metastatic to Lung
(Presented by: MSK Surgical Fellow Dr. Sushmita Gordhandas, MSK Pathologist Dr. Amir Momeni Boroujeni, MSK GYN Medical Oncologist Dr. Martee L. Hensley)

Presentation 2: Uterine LMS: 1st Line Chemotherapy Discussion
(Presented by: MSK GYN Medical Oncologist Dr. Martee L. Hensley)

Download event brochure to see featured panelists and moderators.

Register Now

Friday, March 31, 2023
6-7:30PM IST | 8:30-10AM ET

I would like to receive messages for this and future events via:

*Your information will only be used for international events. We will not share, sell, or otherwise distribute it.